Secondary Myelodysplastic Syndrome

specific

A myelodysplastic syndrome resulting from chemotherapy or radiation therapy for cancer or exposure to certain chemicals.

36

Centers

9

Active Trials

Cancer Funding

Top Centers for Secondary Myelodysplastic Syndrome(36)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
68.3
2
NCI Comprehensive
Active Research Program
68.3
3
NCI Comprehensive
Active Research Program
68.3
4
NCI Comprehensive
Active Research Program
68.3
5
NCI Comprehensive
Active Research Program
68.3
6
NCI Comprehensive
Active Research Program
68.3
7
NCI Comprehensive
Active Research Program
68.3
8
Active Research Program
68.3
9
Active Research Program
68.3
10
NCI Comprehensive
45.8
11
NCI Comprehensive
45.8
1245.8
13
NCI Comprehensive
45.8
14
NCI Comprehensive
45.8
15
NCI Comprehensive
45.8
16
NCI Comprehensive
45.8
17
NCI Comprehensive
45.8
18
NCI Comprehensive
45.8
1945.8
2045.8
21
NCI Comprehensive
45.8
2245.8
23
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
45.8
24
NCI Comprehensive
45.8
25
NCI Comprehensive
45.8
26
NCI Comprehensive
45.8
2745.8
2845.8
29
NCI Comprehensive
45.8
30
NCI Comprehensive
45.8
31
NCI Comprehensive
45.8
3245.8
33
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
45.8
3445.8
3545.8
3645.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →